Skip to main content
. 2021 Apr 7;16(3):357–367. doi: 10.1007/s11523-021-00807-4

Fig. 3.

Fig. 3

Progression-free survival in all patients treated with a AAP and b AAP-PD among those with and without cardiovascular comorbidities (first-line data included for comparative purposes). AAP abiraterone acetate plus prednisone/prednisolone, AAP-PD AAP after docetaxel, CV cardiovascular